Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BVS
KURA
Add up to 3 more stocks
BVS
Bioventus Inc.
-3.11%
$13.10-0.42Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$887.50M
52W Range
$6.37 - $15.89
KURA
Kura Oncology, Inc.
-0.85%
$10.53-0.09Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$934.79M
52W Range
$7.36 - $13.90
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 17.01 | N/A |
| Forward P/E | 16.82 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.89 | 19.30 |
| P/S Ratio | 1.53 | 12.10 |
| P/FCF Ratio | 9.41 | N/A |
| EV/EBITDA | 10.48 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 68.0% | 94.7% |
| Operating Margin | 10.6% | -449.9% |
| Net Margin | 9.4% | -384.3% |
| ROE | 23.9% | -612.8% |
| ROA | 8.1% | -50.5% |
| ROIC | 11.4% | -67.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.69 | 4.73 |
| Quick Ratio | 1.17 | 4.71 |
| Debt/Equity | 1.16 | 0.50 |
| Interest Coverage | 2.21 | -200.81 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.